Overview   Programme   Selection Committee & Team   Participants   Partners & Sponsors   Venues & Accommodation   Testimonials   Received Applications   Confirmed Attendees   Optional Visits at Biopôle   Awards   Registration
Login

Email  
Password  

 
Global Partner  
    
Founded in 1805 in Geneva, Pictet & Cie SA is today one of Switzerland’s largest private banks, and the leading independent asset management specialist in Europe, with CHF 436 billion (EUR 402 billion) in assets under management and custody at December 2015. Pictet & Cie SA is a partnership owned and managed by eight general partners with unlimited liability for the bank’s commitments. The Pictet Group, based in Geneva, employs more than 3,900 staff. The group has offices in the following financial centres: Amsterdam, Barcelona, Basel, Dubai, Florence, Frankfurt, Hong Kong, Lausanne, London, Luxembourg, Madrid, Milan, Montreal, Nassau, Osaka, Paris, Rome, Singapore, Taipei, Turin, Tokyo, Verona and Zurich. 
 
 
Hosting Partner
 
The State of Vaud is one of the main centers of research and innovation in Switzerland, with the largest campus in the country and several research centers as well as industries of international reputation, particularly in life sciences, micro-nanotechnologies, ICT and cleantech.
Through its support to the Healthtech Summit 2016, the State of Vaud aims to highlight the potential of its state-of-the-art industries and start-ups, as well as the very attractive economic and scientific conditions in the region.
The Office for Economic Affairs (SPECo) supports companies that are located in the State of Vaud, especially those involved in the sectors of advanced technology and industry. SPECo advises entrepreneurs and puts them in contact with organisations that are appropriate to their specific needs. SPECo can also provide direct financial support.
 
     
Gold Partners


Bryan, Garnier & Co is a European, full service growth-focused independent investment banking partnership founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. Our focus is on key growth sectors of the economy including Technology, Media, Telecoms, Healthcare, Smart Industries, Specialty Retail and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Geneva, New York and New Delhi. The firm is a member of the London Stock Exchange and Euronext.
At STRAMMER, we believe in continuous innovation. We provide tailored solutions through our Full Talent Solution® approach, helping our clients to meet their business needs, anticipate future challenges and enable their organisations to deliver sustainable performance.
 
 
 
Silver Partners
 

Boston Scientific Europe is the European branch of Boston Scientific Corporation, with offices in 19 countries and a market presence in 52 countries. We transform lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. Our products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. We demonstrate continued commitment to meaningful clinical science by conducting carefully designed clinical studies and by sponsoring studies that seek tailored therapy options to optimize patient outcomes.



Medtronic is the world’s largest medical technology company, offering an unprecedented breadth and depth of innovative therapies to fulfill our Mission of alleviating pain, restoring health, and extending life. Last year, more than 9 million people benefited from our medical therapies, which treat cardiac and vascular diseases, diabetes, and neurological and musculoskeletal conditions. 


Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck GHI has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck. With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck's expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.



Bronze Partner

Euronext is the primary exchange in the Euro zone with over 1 300 issuers worth €2.6 trillion in market capitalisation, an unmatched blue-chip franchise consisting of 20+ issuers in the EURO STOXX 50® benchmark and a strong, diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. Euronext operates regulated markets, Alternext and the Free Market; in addition it offers EnterNext, which facilitates SMEs’ access to capital markets.


Local Support Partners


 Biopôle is a life sciences community bringing together industry and academia, based in Lausanne, Switzerland. It offers a world-class combination of infrastructure, added value services, living space and community engagement where partners can thrive and bring science to life.  While it is open to all therapeutic areas, the main focus of Biopôle is on developing innovative solutions in the fields of oncology, immunology and personalised medicine. These solutions can cover a wide spectrum, from diagnostics to therapeutics, medical devices, nutrition and digital health. Biopôle works with both industry and academia to ensure that there is communal knowledge and appreciation of what projects they are pursuing and where there might be opportunities for synergies and collaboration. Biopôle SA, the management and promotion organisation for the park, was established in 2004 as a limited company by the public authorities of the Canton of Vaud. The organisation is led by an executive team and Board of Directors with an extensive track-record in life scienceswww.biopole.ch

EPFL is Europe’s most cosmopolitan technical university with students, professors and staff from over 120 nations. A dynamic environment, open to Switzerland and the world, EPFL is centered on its three missions: teaching, research and technology transfer. EPFL works together with an extensive network of partners including other universities and institutes of technology, developing and emerging countries, secondary schools and colleges, industry and economy, political circles and the general public, to bring about real impact for society.


Media Partners




 
Cukierman & Co. Life Sciences (CLS) is a leading specialized investment house delivering high quality, senior level advice to the global Life Sciences sectors, including biotechnology and pharmaceuticals, medical devices and healthcare information technology.





Health 2.0 is the leading showcase of cutting edge innovation that's transforming health and health care, bringing a fresh approach to the space. It brings together the best minds, resources and technology for compelling panels, discussions and product demonstrations.



 
The MedTech Strategist, a leading information and investment conferences provider focused exclusively on the under-served medtech market, is led by managing partners and co-editors-in-chief David Cassak and Stephen Levin, along with a seasoned editorial team and staff. The company launched The MedTech Strategist, a publication broadly covering the most important topics and trends in medical devices today, in September 2014. Featuring a wide range of editorial offerings — from interviews with industry leaders to stories on leading companies, profiles of ground-breaking start-ups and analyses of dynamic clinical markets and technology trends — The MedTech Strategist, in 18 issues per year (40-52 pages per issue), explores how innovation plays out in all of its various forms — clinical, technological, business model, marketplace, and financing — in the global medical device arena. For subscription information and current offers, as well as coverage in the 400+ articles published to date, and information on upcoming medtech investment events, please visit the company’s website.

 
 

For entrepreneurs who are transforming healthcare, StartUp Health Academy is a global, long-term coaching program and trusted peer network focused on increasing the equity value of its startups. Unlike traditional accelerators, StartUp Health Academy’s full-time team of entrepreneur coaches provide unparalleled programming and access to relationships for every stage of a company’s lifecycle.


 



Powered by e-unlimited.com
Registration & Profiling Platform v1.3.6297.20376
Copyright ©1998-2017 Europe Unlimited - All rights reserved